X-100296851-C-T
Variant summary
Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2
The NM_001184880.2(PCDH19):c.2873G>A(p.Arg958Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000167 in 1,206,546 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 82 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R958W) has been classified as Uncertain significance.
Frequency
Consequence
NM_001184880.2 missense
Scores
Clinical Significance
Conservation
Publications
- developmental and epileptic encephalopathy, 9Inheritance: XL, Unknown Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
- X-linked complex neurodevelopmental disorderInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- Dravet syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -19 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| PCDH19 | NM_001184880.2 | c.2873G>A | p.Arg958Gln | missense_variant | Exon 6 of 6 | ENST00000373034.8 | NP_001171809.1 | |
| PCDH19 | NM_001105243.2 | c.2732G>A | p.Arg911Gln | missense_variant | Exon 5 of 5 | NP_001098713.1 | ||
| PCDH19 | NM_020766.3 | c.2729G>A | p.Arg910Gln | missense_variant | Exon 5 of 5 | NP_065817.2 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| PCDH19 | ENST00000373034.8 | c.2873G>A | p.Arg958Gln | missense_variant | Exon 6 of 6 | 1 | NM_001184880.2 | ENSP00000362125.4 | ||
| PCDH19 | ENST00000255531.8 | c.2732G>A | p.Arg911Gln | missense_variant | Exon 5 of 5 | 1 | ENSP00000255531.7 | |||
| PCDH19 | ENST00000420881.6 | c.2729G>A | p.Arg910Gln | missense_variant | Exon 5 of 5 | 1 | ENSP00000400327.2 | 
Frequencies
GnomAD3 genomes  0.000117  AC: 13AN: 111282Hom.:  1  Cov.: 22 show subpopulations 
GnomAD2 exomes  AF:  0.000194  AC: 35AN: 180554 AF XY:  0.000284   show subpopulations 
GnomAD4 exome  AF:  0.000174  AC: 191AN: 1095210Hom.:  0  Cov.: 29 AF XY:  0.000214  AC XY: 77AN XY: 360638 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000988  AC: 11AN: 111336Hom.:  0  Cov.: 22 AF XY:  0.000149  AC XY: 5AN XY: 33544 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 9    Benign:3 
- -
- -
- -
not specified    Benign:1 
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Inborn genetic diseases    Benign:1 
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
PCDH19-related disorder    Benign:1 
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
not provided    Benign:1 
PCDH19: BP4, BS2 -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at